Stress Disorders, Post Traumatic / Post Traumatic Stress Disorders · Journal article
The European Journal of General Practice · July 21, 2026
Well-designed and adequately powered for the question it asks.
This secondary analysis of the PICTURE RCT demonstrates that a brief GP-delivered narrative exposure intervention for ICU survivors with PTSD symptoms produces clinically meaningful improvements in health-related quality of life over 12 months. The effects emerged gradually with transient improvement in subjective wellbeing at 6 months and sustained improvement in overall quality of life at 12 months, with only about one quarter mediated by PTSD symptom reduction.
Randomised controlled trial with 319 participants and longitudinal follow-up. Adult ICU survivors with at least moderate PTSD symptoms. n = 319.
At 6 months, the intervention group showed transient improvement in EQ VAS (β = 5.85; 95% CI 0.84-10.87) At 12 months, delayed improvement in EQ index was observed (β = 0.075; 95% CI 0.014-0.136) About one quarter of the 12-month EQ index effect was mediated by PTSD symptom reduction at 6 months
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
General practitioners can deliver brief narrative exposure interventions to ICU survivors with PTSD symptoms with expectation of meaningful quality-of-life improvements emerging over 12 months. The intervention's benefits extend beyond PTSD symptom reduction alone, particularly improving anxiety/depression and mobility domains.
Secondary analysis of a 319-patient RCT demonstrating clinically meaningful quality-of-life improvements from a brief GP-delivered intervention for ICU survivors with PTSD symptoms.
As stated by the source record.
Quoted from the source exactly as published.
General practitioners can deliver brief narrative exposure interventions to ICU survivors with PTSD symptoms with expectation of meaningful quality-of-life improvements emerging over 12 months. The intervention's benefits extend beyond PTSD symptom reduction alone, particularly improving anxiety/depression and mobility domains.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
Background. Intensive care unit (ICU) survivors frequently experience symptoms of post-traumatic stress disorder (PTSD) and reduced health-related quality of life (HRQoL), yet evidence for effective post-ICU interventions in primary care remains limited. This secondary analysis of the PICTURE randomised controlled trial provides an in-depth evaluation of HRQoL trajectories and potential treatment mechanisms.Methods. The analysis included 319 adult ICU survivors with at least moderate PTSD symptoms, randomised to a brief general practitioner (GP)-delivered narrative exposure intervention or enhanced usual care. Longitudinal mixed-effects models estimated treatment-by-time effects on HRQoL, based on EuroQol Five-Dimension Five-Level (EQ-5D-5L) index and visual analog scale (VAS), with mediation via PTSD symptom change assessed using structural equation modelling.Results. The mean baseline EQ index was 0.71 ± 0.27 and EQ VAS was 60.7 ± 19.4. Mixed-effects models showed a transient improvement in EQ VAS at 6 months in the intervention group (ß = 5.85; 95% CI 0.84-10.87), followed by a delayed improvement in the EQ index at 12 months (ß = 0.075; 95% CI 0.014-0.136). About one quarter of the 12-month EQ index effect was mediated by PTSD symptom reduction at 6 months. Domain-level analyses indicated greater improvement in anxiety/depression and mobility.Conclusions. In ICU survivors with PTSD symptoms, a brief GP-delivered psychological intervention was associated with clinically meaningful improvements in health-related quality of life over 12 months, with effects emerging over time and only partly explained by PTSD symptom reduction.Trial registration. ClinTrials.gov: NCT03315390 (Registration date: 2017-10-20); German Clinical Trials Register (DRKS): DRKS00012589 (Registration date: 2017-10-17).
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.